CORAL GABLES, Fla., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and ...
Ellipsys Commercial Technology Group plans to hold its first-ever exclusive networking and education event in October for the group’s Charter Members. The Ellipsys Catalyst event, scheduled for Oct. 1 ...
MANCHESTER, N.H., Sept. 17, 2025 /PRNewswire/ -- Catalyst Power Holdings LLC ("Catalyst Power"), an independent provider of retail energy and complementary energy solutions for large commercial and ...
NAPLES, Fla.--(BUSINESS WIRE)--Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in the orthopedics market, ...
(RTTNews) - Shares of Catalyst Pharmaceuticals, Inc. (CPRX) are climbing over 3 percent on Wednesday after the announcement of commercial launch of Agamree in the U.S. The drug was authorized by the U ...
Ellipsys Commercial Technology Group announced that its annual Ellipsys Catalyst event, held from May 5 to 7, 2025 in Indianapolis, Ind., brought Ellipsys members and vendor partners together from ...
PITTSBURGH and CAESAREA, Israel, July 17, 2025 /PRNewswire/ -- Catalyst MedTech, a national leader in diagnostic imaging solutions and service, announced today the expansion of its strategic ...